XML 21 R8.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities      
Net income $ 312,376 $ 128,579 $ 224,270
Adjustments to reconcile net income to net cash from operating activities:      
Depreciation and amortization 420,692 367,162 336,274
Loss on early retirement of debt 0 176 11,995
Gain on sale of operating properties, including land (174,384) (382) (49,901)
Distributions of income from joint ventures 9,645 8,389 14,843
Income (Loss) from Equity Method Investments (9,777) (8,052) (14,783)
Share-based compensation 15,397 13,942 15,235
Receipts for settlement of forward interest rate swaps 0 0 (20,430)
Net change in operating accounts and other 3,518 9,505 38,094
Net cash from operating activities 577,467 519,319 555,597
Cash flows from investing activities      
Development and capital improvements, including land (428,714) (427,247) (407,558)
Acquisition of operating properties (629,959) 0 (436,305)
Proceeds from sales of operating properties, including land 254,717 753 67,572
Increase in non-real estate assets (4,032) (7,498) (17,197)
Other 3,597 4,390 1,043
Net cash from investing activities (804,391) (429,602) (792,445)
Cash flows from financing activities      
Common shares issued 759,209 0 353,213
Distributions to common shareholders and non-controlling interests (343,039) (333,360) (317,253)
Borrowings on unsecured credit facility and other short-term borrowings 0 358,000 1,217,000
Repayments on unsecured credit facility and other short-term borrowings 0 (402,000) (1,173,000)
Repayment of notes payable 0 (100,000) (746,730)
Proceeds from notes payable 0 782,823 889,979
Payment of deferred financing costs (1,346) (1,308) (5,965)
Other 6,547 3,162 3,500
Net cash from financing activities 421,371 307,317 220,744
Net increase (decrease) in cash, cash equivalents, and restricted cash 194,447 397,034 (16,104)
Cash, cash equivalents, and restricted cash, beginning of year 424,533 27,499 43,603
Cash, cash equivalents, and restricted cash, end of year 618,980 424,533 27,499
Reconciliation of cash, cash equivalents, and restricted cash to the Consolidated Balance Sheets [Abstract]      
Cash and cash equivalents 613,391 420,441 23,184
Restricted cash 5,589 4,092 4,315
Total cash, cash equivalents, and restricted cash 618,980 424,533 27,499
Supplemental information      
Cash paid for interest, net of interest capitalized 97,301 90,297 71,248
Cash paid for income taxes 2,181 2,292 1,291
Supplemental schedule of noncash investing and financing activities      
Distributions declared but not paid 88,786 84,147 80,973
Value of shares issued under benefit plans, net of cancellations 18,627 19,560 18,249
Accrual associated with construction and capital expenditures 24,313 29,611 27,162
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability $ 0 $ 676 $ 15,017